Wolverine Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-853,416
| Closed | -$3.24M | – | 1674 |
|
|
2020
Q1 | $3.24M | Buy |
853,416
+798,647
| +1,458% | +$3.03M | 0.05% | 217 |
|
|
2019
Q4 | $278K | Buy |
+54,769
| New | +$278K | ﹤0.01% | 659 |
|
|
2015
Q4 | – | Sell |
-38,108
| Closed | -$217K | – | 1340 |
|
|
2015
Q3 | $217K | Sell |
38,108
-92,400
| -71% | -$526K | 0.01% | 658 |
|
|
2015
Q2 | $973K | Sell |
130,508
-20,200
| -13% | -$151K | 0.02% | 409 |
|
|
2015
Q1 | $901K | Buy |
150,708
+89,200
| +145% | +$533K | 0.02% | 406 |
|
|
2014
Q4 | $465K | Sell |
61,508
-101,467
| -62% | -$767K | 0.01% | 533 |
|
|
2014
Q3 | $845K | Sell |
162,975
-75,392
| -32% | -$391K | 0.02% | 421 |
|
|
2014
Q2 | $1.03M | Buy |
238,367
+50,400
| +27% | +$217K | 0.02% | 348 |
|
|
2014
Q1 | $768K | Buy |
+187,967
| New | +$768K | 0.02% | 404 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 1643 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 1558 |
|